BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence

Licence of up to 20 years, payable in shares, as Malaysia commits RM1 billion to digitalizing public healthcareKUALA LUMPUR, Malaysia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. NASDAQ:BGLC ("Company" or "BGLC") today announced plans to build AI applications for Malaysian healthcare…